相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Understanding Mechanisms of Resistance in the Epithelial Growth Factor Receptor in Non-Small Cell Lung Cancer and the Role of Biopsy at Progression
Mark A. Socinski et al.
ONCOLOGIST (2017)
Immunotherapy for Lung Malignancies From Gene Sequencing to Novel Therapies
Jonathan Chee et al.
CHEST (2017)
Biomarkers related to immunosenescence: relationships with therapy and survival in lung cancer patients
Danay Saavedra et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
A Phase III Clinical Trial of the Epidermal Growth Factor Vaccine CIMAvax-EGF as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
Pedro C. Rodriguez et al.
CLINICAL CANCER RESEARCH (2016)
The safety of afatinib for the treatment of non-small cell lung cancer
Feliciano Barron et al.
EXPERT OPINION ON DRUG SAFETY (2016)
An enzyme immunoassay for determining epidermal growth factor (EGF) in human serum samples using an ultramicroanalytical system
Elisa María Castells Martínez et al.
JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY (2016)
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial
Louis Fehrenbacher et al.
LANCET (2016)
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst et al.
LANCET (2016)
Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial
Keunchil Park et al.
LANCET ONCOLOGY (2016)
Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer
Martin Reck et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Group sequential monitoring based on the weighted log-rank test statistic with the Fleming-Harrington class of weights in cancer vaccine studies
Takahiro Hasegawa
PHARMACEUTICAL STATISTICS (2016)
Targeted Therapy and Checkpoint Immunotherapy Combinations for the Treatment of Cancer
Paul E. Hughes et al.
TRENDS IN IMMUNOLOGY (2016)
Vaccine development: From concept to early clinical testing
Anthony L. Cunningham et al.
VACCINE (2016)
Kirsten Ras* oncogene: Significance of its discovery in human cancer research
Nobuo Tsuchida et al.
ONCOTARGET (2016)
Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death
Stefania Di Blasio et al.
ONCOIMMUNOLOGY (2016)
Future perspectives in cancer immunotherapy
Marinos Tsiatas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2016)
CIMAvax EGF (EGF-P64K) vaccine for the treatment of non-small-cell lung cancer
Tania Crombet Ramos et al.
EXPERT REVIEW OF VACCINES (2015)
Antibody-based immunotherapy of solid cancers: progress and possibilities
Christopher F. Nicodemus
IMMUNOTHERAPY (2015)
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer
Julie Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer
H. Borghaei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Biomarker development in the context of urologic cancers
Gary J. Kelloff et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2015)
The past, present and future of immunotherapy against tumor
Tao Jiang et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2015)
Immunotherapy for bladder cancer
Oliver Fuge et al.
RESEARCH AND REPORTS IN UROLOGY (2015)
Monitoring the immune competence of cancer patients to predict outcome
Serena Chang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2014)
Paracrine Network: Another Step in the Complexity of Resistance to EGFR Blockade?
Ramon Salazar et al.
CLINICAL CANCER RESEARCH (2014)
Molecular epidemiology of lung cancer and geographic variations with special reference to EGFR mutations
Tetsuya Mitsudomi
TRANSLATIONAL LUNG CANCER RESEARCH (2014)
Chemotherapy Delivered After Viral Immunogene Therapy Augments Antitumor Efficacy Via Multiple Immune-mediated Mechanisms
Zvi G. Fridlender et al.
MOLECULAR THERAPY (2010)
Combining an EGF-based Cancer Vaccine With Chemotherapy in Advanced Nonsmall Cell Lung Cancer
Elia Neninger et al.
JOURNAL OF IMMUNOTHERAPY (2009)
Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine
Beatriz Garcia et al.
CLINICAL CANCER RESEARCH (2008)
Phase II randomized controlled trial of an epidermal growth factor vaccine in advanced non-small-cell lung cancer
Elia Neninger Vinageras et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
分享论文
